Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of
Rochester Medical Corporation Shareholders
NEW YORK -- September 6, 2013
Kirby McInerney LLP is investigating potential claims against the Board of
Directors of Rochester Medical Corporation (“Rochester Medical” or the
“Company”) (NASDAQ: ROCM) related to the proposed acquisition of the Company
by C.R. Bard (“Bard”), a New Jersey-based medical equipment manufacturer.
Under the terms of the agreement, Bard will acquire all outstanding shares of
Rochester Medical for $20.00 per share in cash, for a total transaction value
of approximately $262 million.
The investigation concerns whether the Rochester Medical Board of Directors
violated its fiduciary duties by agreeing to this transaction and whether the
proposed $20.00 per share consideration adequately values Rochester Medical
If you are a Rochester Medical (ROCM) shareholder and wish to obtain
additional information, please contact J. Brandon Walker, Esq. by email at
email@example.com, by telephone at (212) 699-1145 or (888) 529-4787, or by
filling out this contact form.
Kirby McInerney LLP is a New York-based law firm concentrating in securities,
shareholder, whistleblower, antitrust and consumer litigation. For additional
information, please go to www.kmllp.com.
Kirby McInerney LLP
J. Brandon Walker, Esq., 212-699-1145 or 888-529-4787
Press spacebar to pause and continue. Press esc to stop.